San Francisco, CA - 2013 Gastrointestinal Cancers Symposium - San Francisco, CA: Daniel D. Von Hoff MD discusses Abstract LBA148: Randomized phase III study of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic adenocarcinoma of the pancreas (MPACT) during the Oral Abstract Session: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract at the Gastrointestinal Cancers Symposium 2013 here today, Friday January 25, 2013. The Symposium is supported by ASCO, the American Society of Clinical Oncology, ASTRO, The American Society of Radiation Oncology, SSO, Society of Surgical Oncology and the AGA Institute. Over 3,000 physicians, researchers and allied healthcare professionals are attending the meeting which is being held at the Moscone West center in San Francisco and features the latest Gastrointestinal Cancers research in the areas of basic and clinical science. Date: Friday January 25, 2013. Photo by © ASCO/Todd Buchanan 2013 Technical Questions: email@example.com; Phone: 612-226-5154.